Bilateral biosafety bullies: How corporations use bilateral trade channels to weaken biotech regulations
Publication
Report
Across the world, the use of bilateral trade instruments to prise open markets for genetically modified (GM) crops is escalating. To expand business overseas, the biotech industry needs stronger intellectual property rules and weaker biosafety standards.